Skip to content

Immuno -Modulatory Potential of AyurRaksha Kit and Its Preventive Impact on COVID 19 In Delhi Police

â??evaluation of the Immuno Modulatory Potential of AyurRaksha Kit On a Cohort of Delhi Police to Assess Prophylactic Impact on COVID 19 - An Exploratory Studyâ??

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035745
Enrollment
2000
Registered
2021-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Ministry of AYUSH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Police personnel of either sex aged 19-60 years 2.Delhi Police personnel on duty in different units and from 4 districts of Delhi state. 3.Individuals agree to give consent for participation

Exclusion criteria

Exclusion criteria: 1.Police personnelâ??s with severe co morbidities 2.Those who are on any other prophylaxis 3.Those who are presently infected with Covid-19

Design outcomes

Primary

MeasureTime frame
1. Baseline survey would generate information on occurrence of covid19 infection during past 4 months (as reference time) and related epidemiological determi-nants. 2 AS the cohort of susceptible persons is followed after giving prophylactic medi-cines, the observance of new covid19 infection as incidence. Incidence will be counted after the 15 days of intake of medicine. 3 Among those covid19 positive found, would be observed for progress in recov-ery and disease severity. 4 The change in immunity status as measured by ISQ would be as-sessed Timepoint: assessed at baseline, after 60days, and after 120 days.

Secondary

MeasureTime frame
Change in immune status score using ISQ,Timepoint: assessed at baseline, after 60days, and after 120 days.

Countries

India

Contacts

Public ContactDr Sujata Kadam

All India Institute of Ayurveda

dr.ananthramsharma@gmail.com9495130595

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026